Company intelligence / Profile preview

Centre for Eye and Vision Research

Shatin, Hong Kong SARcevr.hk ↗

Ownership: Private
Development stage: Preclinical

Overview

CEVR has developed novel quantum optics-based devices for early detection of age-related macular degeneration and is advancing new techniques for non-invasive retinal imaging. It collaborates with industry partners to develop innovative treatments for dry eye disease. Clinical validation is ongoing; no marketed products yet.

Therapeutic areas: Ophthalmology
Modalities: DeviceSmall moleculeBiologic
Industry: Academic Hospital/University/Research

Partnerships

SCOPE Health Inc. – collaboration on developing technologies/products for dry eye disease and ocular surface conditions

Beyond the preview

Go deeper on Centre for Eye and Vision Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centre for Eye and Vision Research.

Explore the full profile